Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

StarGen gene therapy being tested in phase I/II clinical trial

May 16, 2012

New biomarker for measuring disease severity in patients with diabetic retinopathy

May 16, 2012

First HSP 90-alpha-binding agent with promising antiglaucoma activity

May 16, 2012

NKP-2235 shows unique cytotoxicity profile and synergistic activity with other anticancer agents

May 16, 2012

Early clinical data for ABT-267 monotherapy and combination treatment shows promise

May 15, 2012

Biomarkers of inflammation are associated with AMD severity

May 15, 2012

Gene therapy shows promise for retinal degeneration

May 15, 2012

Gene therapy rescues retinal degeneration in Prom1 knockout mice

May 15, 2012

EMERGE study results presented for pegylated interferon lambda-1a

May 15, 2012

New data presented on brentuximab vedotin in cutaneous T-cell lymphoma

May 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...